Nurse Practitioner, Family · Houston, TX
NPI
1043891047
Since 2021
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$10,000
247 services
Medicare patients, 2024
156
Average age 73
Drug cost, 2024
$3.3M
800 prescriptions
Company payments, 2025
$1,145
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melanie N Ramos was code 99213 (office e&m - established), 189 times for 116 patients. In total Melanie N Ramos billed 247 services in 8 codes, and Medicare paid $10,000.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 189 | 116 | $43.63 | $8,247 |
| 99441 Telephone Services | Facility | 19 | 16 | $23.69 | $450 |
| 38222 Other Organ Systems | Facility | 17 | 17 | $30.43 | $517 |
By year: 2022 $13K for 302 services; 2023 $11K for 253 services; 2024 $10,000 for 247 services.
Medicare prescription drug claims, 2024
In 2024, the drug Melanie N Ramos prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 114 prescriptions and refills. In total Melanie N Ramos wrote 800 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 114 | 200 | 31 | $3,344 |
| Sprycel Dasatinib | 48 | 48 | Under 11 | $274K |
| Venclexta Venetoclax | 46 | 46 | 11 | $244K |
| Jakafi Ruxolitinib Phosphate | 43 | 43 | Under 11 | $550K |
| Iclusig Ponatinib Hcl | 36 | 36 | Under 11 | $650K |
| Allopurinol Generic | 33 | 71 | 13 | $190 |
| Imbruvica Ibrutinib | 32 | 32 | Under 11 | $416K |
| Levofloxacin Generic | 30 | 32 | 11 | $421 |
| Bosulif Bosutinib | 29 | 29 | Under 11 | $415K |
| Hydroxyurea Generic | 29 | 59 | Under 11 | $492 |
| Ondansetron Odt Ondansetron | 19 | 19 | Under 11 | $444 |
| Pantoprazole Sodium Generic | 17 | 21 | Under 11 | $78.28 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 16 | 16 | Under 11 | $172 |
| Cresemba Isavuconazonium Sulfate | 15 | 15 | Under 11 | $88K |
| Tramadol Hcl Generic | 15 | 15 | Under 11 | $42.56 |
Brand drugs: 312 claims; generic drugs: 488 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melanie N Ramos $1,145 ($1,145 in general payments such as food, travel and fees) from 15 companies. The largest payer was Syndax Pharmaceuticals, Inc. with $163.
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. SNDX | 5 | $163 |
| Sobi, Inc SOBI.ST | 4 | $119 |
| Lilly USA, LLC LLY | 4 | $115 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $111 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $109 |
| GlaxoSmithKline, LLC. GSK | 4 | $108 |
| Abbvie Inc. ABBV | 3 | $92.16 |
| Celgene Corporation BMY | 3 | $79.87 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $58.1 |
| Incyte Corporation INCY | 2 | $50.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.